- Forums
- ASX - By Stock
- TLX
- Ann: Telix Reports Q1 2024 Financial Performance
Ann: Telix Reports Q1 2024 Financial Performance, page-26
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.94 |
Change
0.010(0.05%) |
Mkt cap ! $6.721B |
Open | High | Low | Value | Volume |
$20.10 | $20.54 | $19.79 | $50.61M | 2.514M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2874 | $19.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.95 | 55 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2874 | 19.940 |
2 | 3178 | 19.930 |
2 | 3689 | 19.920 |
2 | 4570 | 19.910 |
2 | 3872 | 19.890 |
Price($) | Vol. | No. |
---|---|---|
19.950 | 55 | 1 |
19.970 | 296 | 1 |
19.980 | 1593 | 1 |
20.000 | 7539 | 4 |
20.010 | 2608 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online